S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

FOLD Amicus Therapeutics Inc

9.8734

0.0234 (0.24%)

Pre Market

Last Updated: 07:25:17

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Amicus Therapeutics Charts.

Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Amicus Therapeutics Charts.

Amicus Therapeutics Inc News

Form 8-K - Current report
Wednesday 19 February 2025 (2 hours ago) • Edgar (US Regulatory)

Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
Wednesday 19 February 2025 (2 hours ago) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 13 February 2025 (6 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 13 February 2025 (6 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 13 February 2025 (6 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 13 February 2025 (6 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 13 February 2025 (6 days ago) • Edgar (US Regulatory)

Amicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025
Monday 10 February 2025 (1 week ago) • GlobeNewswire Inc.

Amicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium™ 2025
Monday 3 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Amicus Therapeutics Launches Amicus Ignite, a Proactive Community Funding Programme for Initiatives That Support People Living With Pompe Disease
Thursday 30 January 2025 (3 weeks ago) • Business Wire

Amicus Therapeutics Reports Preliminary 2024 Revenue and Provides 2025 Strategic Outlook
Sunday 12 January 2025 (1 month ago) • GlobeNewswire Inc.

More Amicus Therapeutics Inc News Articles

Digital Brand Media and ... (PK)

TheGlobe com (PK)

Clean Vision (QB)

Asia Broadband (PK)

Intergrated Cannabis Sol... (PK)

Rennova Health (CE)

Super Micro Computer

Voip Pal Com (QB)

Valiant Eagle (PK)

Green Leaf Innovations (PK)

Cann American (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions